CVC  Takeda Ventures

     Office Locations:

9625 Towne Centre Drive
San Diego, CA 92121
Phone: 619-930-8400

Get all office locations for this firm with a National Database subscription or Southern California Database subscription.


  • Early
  • Growth
  • Seed



  • Life Sciences & Healthcare



    Takeda Ventures, Inc. (TVI) is the corporate venture arm of Takeda Pharmaceutical Company Limited (TPC), a pharmaceutical company and the largest in Japan. TVI assumes the role of Takeda's former venture investment group, Takeda Research Investment, Inc., and remains a wholly owned subsidiary of Takeda America Holdings, Inc. The new group continues to seek strategic opportunities to complement and extend internal discovery capabilities, but will additionally explore potentially new business avenues for Takeda through external strategic venture activities. Takeda's strategic investment mandate means that while it will consider product, target and technology opportunities at any stage, the firm's focus is on start-up/seed rounds, through mid-stage financings. TVI intends to maintain a diverse investment portfolio, but is presently concentrating on drugs and biotherapeutics to treat cancer, metabolic disorders (obesity, diabetes, and dyslipidemias), cardiovascular disorders, chronic inflammatory disorders (particularly for gastrointestinal and bone and joint diseases) and diseases for the central nervous system (specifically Alzheimers Disease and schizophrenia). Additional areas of strategic importance are regenerative medicines, RNA and DNA modulation, novel vaccines technologies and innovative protein and peptide biotherapeutics. Currently, TVI does not invest in anti-infective diseases, medical devices, or diagnostics platforms.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    Alessandra Di Bacco Partner
    Robbie Woodman Ph.D Senior Partner


    Recent Funding Events (trailing 12 months):







      hC Bioscience



      Series A Extension


      Code Biotherapeutics



      Series A





      Series C


    Portfolio companies include:


    Recent News: